doi: 10.1136/bmj.n1106.
Which is the best model to assess risk for venous thromboembolism in hospitalised patients?
Affiliations
- PMID: 34045235
- DOI: 10.1136/bmj.n1106
Item in Clipboard
Which is the best model to assess risk for venous thromboembolism in hospitalised patients?
BMJ.
.
Free article
No abstract available
Conflict of interest statement
Competing interests: We have read and understood the BMJ policy on declaration of interests and declare that we have no competing interests. All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: no support from any organisation for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.
Similar articles
-
More on thromboprophylaxis: quantifying risk for venous thromboembolism.Thromb Haemost. 2009 Apr;101(4):791-4. Thromb Haemost. 2009. PMID: 19350133 No abstract available.
-
Extended or shorter prophylaxis for venous thromboembolism in acutely ill hospitalized patients: Updated meta-analysis of randomized trials.Vasc Med. 2019 Apr;24(2):156-158. doi: 10.1177/1358863X18818319. Epub 2019 Feb 12. Vasc Med. 2019. PMID: 30755140 No abstract available.
-
New paradigms in venous thromboprophylaxis of medically ill patients.Thromb Haemost. 2017 Aug 30;117(9):1662-1670. doi: 10.1160/TH17-03-0168. Epub 2017 Jun 22. Thromb Haemost. 2017. PMID: 28640324
-
A modified Khorana risk assessment score for venous thromboembolism in cancer patients receiving chemotherapy: the Protecht score.Intern Emerg Med. 2012 Jun;7(3):291-2. doi: 10.1007/s11739-012-0784-y. Epub 2012 May 1. Intern Emerg Med. 2012. PMID: 22547369 No abstract available.
-
Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update.J Oncol Pract. 2015 May;11(3):e442-4. doi: 10.1200/JOP.2015.004473. Epub 2015 Apr 14. J Oncol Pract. 2015. PMID: 25873061 Review. No abstract available.
Cited by
-
A systematic approach to venous thromboembolism prevention: a focus on UK experience.Res Pract Thromb Haemost. 2022 Dec 27;7(1):100030. doi: 10.1016/j.rpth.2022.100030. eCollection 2023 Jan. Res Pract Thromb Haemost. 2022. PMID: 36760776 Free PMC article.
-
Association between gastroesophageal reflux disease and venous thromboembolism: A Mendelian randomization study.Medicine (Baltimore). 2024 Nov 22;103(47):e40680. doi: 10.1097/MD.0000000000040680. Medicine (Baltimore). 2024. PMID: 39809153 Free PMC article.
-
Immune-mediated inflammatory diseases and risk of venous thromboembolism: A Mendelian randomization study.Front Immunol. 2022 Dec 13;13:1042751. doi: 10.3389/fimmu.2022.1042751. eCollection 2022. Front Immunol. 2022. PMID: 36582224 Free PMC article.
-
The CLUE postsurgery VTE risk instrument for abdominal and pelvic surgery: validation of patient risk factor component.Blood Adv. 2025 Aug 12;9(15):3837-3844. doi: 10.1182/bloodadvances.2024015515. Blood Adv. 2025. PMID: 40354313 Free PMC article.
-
The role of health policy in the prevention of venous thromboembolism in the UK National Health Service-Learning from the past, looking to the future.Future Healthc J. 2024 Feb 28;11(1):100016. doi: 10.1016/j.fhj.2024.100016. eCollection 2024 Mar. Future Healthc J. 2024. PMID: 38646038 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
